Letter by Weir Regarding Article, "Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity"

MeSH terms

• Glucagon-Like Peptides* / adverse effects
• Glucagon-Like Peptides* / therapeutic use
• Heart Failure* / drug therapy
• Heart Failure* / physiopathology
• Humans
• Obesity* / drug therapy
• Quality of Life*
• Stroke Volume* / drug effects